CARBIDOPA AND LEVODOPA 200 mg/1

Carbidopa and Levodopa 200 mg/1 extended-release tablets are designed to manage symptoms of Parkinson's disease. This combination medication helps improve muscle control and reduce tremors.

Carbidopa and Levodopa is primarily used to treat Parkinson's disease, a condition that affects the nervous system. The medication works by increasing the levels of dopamine in the brain, which helps to alleviate symptoms such as tremors, stiffness, and difficulty moving. This extended-release formulation is designed to provide a steady release of the active ingredients over an extended period, helping to maintain consistent symptom control throughout the day.

Common effects of Carbidopa and Levodopa may include nausea, dizziness, and headache. Some users may also experience drowsiness or lightheadedness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Carbidopa and Levodopa should be handled with care. It is important to follow the prescribed dosage and administration instructions. Patients with a history of heart, liver, or kidney disease should use this medication with caution. Always store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Carbidopa and Levodopa may interact with certain medications, including other Parkinson's disease treatments, antidepressants, and blood pressure medications. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, alcohol should be avoided while taking this medication as it can increase the risk of side effects.